Douglas Melton, a developmental biologist at the Stem Cell Research Institute at Harvard University, and colleagues recently reported a new technique in the journal Cell to successfully transform human embryonic stem cells （ESC） or induced pluripotent stem cells （iPSCs） As functional pancreatic β cells. These beta cells secrete insulin to regulate glucose levels, as do normal beta cells. And mouse experimental results have shown that these cells can cure type 1 diabetes.